STOCK TITAN

Establishment Labs Hldgs Inc SEC Filings

ESTA Nasdaq

Welcome to our dedicated page for Establishment Labs Hldgs SEC filings (Ticker: ESTA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking Establishment Labs’ march toward global regulatory approvals means digging through dense SEC documents and clinical data tables. Whether you want the latest cost breakdown of Motiva IDE trials or need to see when executives buy shares after a new CE-mark, our platform turns hours of research into minutes.

Start with the filings most investors ask for: the Establishment Labs quarterly earnings report 10-Q filing for production cost trends, the Establishment Labs annual report 10-K simplified for R&D pipeline details, and every Establishment Labs 8-K material events explained to track FDA milestones. Each document arrives in real time directly from EDGAR, then Stock Titan’s AI distills the medical device jargon so you can focus on numbers that move the model.

Need insider context? Our alerts surface Establishment Labs insider trading Form 4 transactions and display Establishment Labs Form 4 insider transactions real-time, highlighting option exercises or open-market buys that often precede material announcements. Governance questions are answered in the Establishment Labs proxy statement executive compensation, where AI flags pay structures tied to regulatory achievements.

  • Compare manufacturing expansion costs across quarters with instant charts from the 10-Q.
  • Monitor Establishment Labs executive stock transactions Form 4 for sentiment shifts.
  • Use our narrative summaries for Establishment Labs earnings report filing analysis when modeling margins.
  • Save time understanding Establishment Labs SEC documents with AI—no medical dictionary required.

From biocompatibility disclosures to litigation updates, Stock Titan provides Establishment Labs SEC filings explained simply, so analysts, clinicians, and long-term investors can act with confidence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Edward J. Schutter, a director of Establishment Labs Holdings Inc. (ESTA), received 457 common shares as payment in lieu of a quarterly cash retainer under the company’s Outside Director Compensation Policy. The shares were issued under the Issuer’s 2018 Equity Incentive Plan and were valued based on the closing market price used to determine the share equivalent. After this issuance the reporting person beneficially owns 138,015 shares, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Establishment Labs Holdings Inc. (ESTA) director Ann Custin acquired 503 common shares on 09/30/2025 at a price of $40.99 per share. The shares were issued under the company’s 2018 Equity Incentive Plan and were elected in lieu of a quarterly cash retainer under the issuer’s Outside Director Compensation Policy; the number of shares was determined using the closing price on the last trading day of the quarter. Following the transaction, the reporting person beneficially owned 21,087 shares. The Form 4 was signed by the company’s CFO by power of attorney on 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Establishment Labs Holdings director Nicholas Sheridan reported acquiring 609 common shares on 09/30/2025 at a price of $40.99 per share. These shares were issued under the company’s 2018 Equity Incentive Plan and represent shares elected to be received in lieu of a quarterly cash retainer under the issuer’s Outside Director Compensation Policy.

After the transaction the reporting person directly beneficially owned 1,076,532 shares. An additional 19,090 shares are noted as indirectly beneficially owned via the reporting person’s spouse. The Form 4 discloses this routine director compensation election and does not show derivative transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Reporting person: Leslie Gillin, a director of Establishment Labs Holdings Inc. (ESTA), acquired common shares as director compensation.

Transaction details: On 09/30/2025 the reporting person received 411 common shares issued under the company's 2018 Equity Incentive Plan at an effective price of $40.99 per share, representing shares elected in lieu of a quarterly cash retainer. Following the issuance the reporting person beneficially owned 15,516 common shares directly. The transaction was reported on Form 4 and signed by power of attorney on 10/01/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

JW Asset Management, JW Partners, JW Opportunities Fund, JW GP and Jason G. Wild reported writing and selling 940 call options on Establishment Labs Holdings Inc. (ESTA) on 08/22/2025. Each option contract covers 100 shares, so the transaction represents rights on 94,000 shares with a $42.50 strike and an option price of $2.1802 per share. The reported position shows 94,000 underlying shares associated with the calls and is held indirectly through affiliated entities. The filing identifies the advisor and affiliated entities as joint reporting persons and explains their relationships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Lewin Nicholas Sheridan, identified as a director of Establishment Labs Holdings, filed a Form 4 dated 08/14/2025 reporting insider transactions in the company’s common stock. The filing shows a purchase of 2,600 common shares at $37.85 and separately lists a disposition of 1,075,923 common shares. Following the reported transactions, the Form 4 shows 19,090 shares beneficially owned, held indirectly. A footnote states the shares are held by the reporting person’s spouse. The Form was signed by the company’s CFO by power of attorney on 08/14/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Capital Research Global Investors reports beneficial ownership of 1,024,417 shares of Establishment Labs Holdings Inc., equal to 3.5% of 28,917,254 shares outstanding. The filing states that CRGI is a division of Capital Research and Management Company and related investment management entities that provide services under the name "Capital Research Global Investors." CRGI reports sole voting power and sole dispositive power over the 1,024,417 shares.

The filing further certifies the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The filing is categorized as an investment adviser (Type: IA).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Lewin N. Sheridan, a director of Establishment Labs Holdings Inc. (ESTA), reported transactions dated 08/13/2025. The Form 4 discloses a disposition of 1,075,923 common shares and an acquisition of 2,300 common shares at a price of $34.2955 per share. Following the reported transactions the filing shows 16,490 common shares beneficially owned indirectly. A footnote states the shares are held by the reporting person’s spouse. The form was submitted by a single reporting person and executed under power of attorney.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Filippo Caldini, who is listed as Chief Executive Officer and a director of Establishment Labs Holdings Inc. (ESTA), reported a purchase of common shares on 08/11/2025. The amended Form 4/A shows a purchase of 2,850 common shares at $35.20 per share, resulting in reported beneficial ownership of 35,245 shares. The transaction is reported with code P and the ownership is listed as direct (D).

The filing is an amendment (Form 4/A) submitted by a single reporting person and was signed on behalf of the reporting person by Rajbir S. Denhoy, Chief Financial Officer, by power of attorney. The document does not state total outstanding shares or the percentage that 35,245 shares represent, so the filing alone does not establish the transaction's materiality to shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Establishment Labs Hldgs (ESTA)?

The current stock price of Establishment Labs Hldgs (ESTA) is $40.12 as of October 8, 2025.

What is the market cap of Establishment Labs Hldgs (ESTA)?

The market cap of Establishment Labs Hldgs (ESTA) is approximately 1.2B.
Establishment Labs Hldgs Inc

Nasdaq:ESTA

ESTA Rankings

ESTA Stock Data

1.17B
25.85M
10.74%
104.74%
17.69%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
Costa Rica
ALAJUELA